FDAnews Device Daily Bulletin
March 14, 2005 | Vol. 2 No. 51
A U.S. patent has been issued covering certain aspects of Applied NeuroSolutions' (APNS) Alzheimer's blood diagnostic technology.
Restore Medical, a provider of medical technologies to address sleep-disordered breathing, announced that its Pillar Procedure is now available internationally.
SanguiBioTech has been awarded the CE mark for its "Chitoskin" wound pads, authorizing the company to distribute and sell this medical product in the member countries of the European Union, effective immediately.
Medwave has signed an OEM supply and license agreement with Analogic, a leading developer and manufacturer of complete, innovative systems and advanced subsystems for medical imaging and patient monitoring platforms.
Ontario could prevent deaths and injuries to workers
and save millions of dollars by making it mandatory for all healthcare workplaces
to use safety-engineered needles and other sharp medical devices, a coalition
of unions said.
Nanogen, developer of advanced diagnostic products, announced that it was issued U.S. Patent No. 6,864,071, "Multiplex amplification and separation of nucleic acid sequences using ligation-dependent strand displacement amplification and bioelectronic chip technology," by the U.S. Patent and Trademark Office.
Sigma Global, a direct-to-consumer marketer of medical devices and pharmaceuticals, announced that it has completed a private placement with an institutional investor for $2 million in preferred stock.
Eastman Kodak is rolling out a higher-speed X-ray film that can halve a patient's exposure to radiation without blurring image quality. It is the first X-ray film in a generation to offer a 50 percent or better drop in radiation dosage, company researchers say.
Neothermia, a developer and marketer of minimally invasive systems for the diagnosis of breast cancer, announced that Thomas Tully, President and CEO, has informed the Board of Directors of his intention to retire, effective April 1. Tully will be succeeded by Christopher Bleck, currently Executive Vice President, Marketing and Sales.
Inverness Medical Innovations and its subsidiary, Wampole Laboratories, announced the availability of its new fecal occult blood (FOB) test.
Pyng Medical has, effective Feb. 28, delivered orders for several hundred F.A.S.T.1 Systems into Europe through their rapidly expanding distribution network.
Altair Nanotechnologies announced that it has terminated the employment of its former President, Rudi Moerck. Alan Gotcher, Chief Executive Officer, will assume the additional responsibilities of President.
Medical devicemaker LMA International has priced its initial public offer at 88 Singapore cents a share.
Acrongenomics, a research and development company focused in the field of nanobiotechnology, is exploring future prospects by evaluating the technology behind existing implementations of PCR, ELISA and Real Time PCR.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.